Patent Assignment
Reel/Frame 046608/0983
Assignment of Assignor's Interest
Recorded: 2018-08-09
Pages: 4
Assignee
THE FRED HUTCHINSON CANCER RESEARCH CENTER
1100 FAIRVIEW AVENUE NORTH, P.O. BOX 19024, SEATTLE, WASHINGTON, 98109
Covered Property
(1)
Enhanced Generation of Cytotoxic T-Lymphocytes by Il-21 Mediated FOXP3 Suppression
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License
Aug 9, 2018
From: THE FRED HUTCHINSON CANCER RESEARCH CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 046762/0849 →
Merger and Change of Name
Sep 27, 2022
From: FRED HUTCHINSON CANCER RESEARCH CENTER; SEATTLE CANCER CARE ALLIANCE
To: FRED HUTCHINSON CANCER CENTER
Reel/Frame 061613/0897 →